The potential contribution of medicines to falls in older persons and the acceptance of pharmacist intervention

Show simple item record Richardson, M. O'Dwyer, C. Gaskin, J. Conyard, E. Murphy, Kevin D. 2020-04-17T11:59:25Z 2020-04-17T11:59:25Z 2020-03
dc.identifier.citation Richardson, M., O’Dwyer, C., Gaskin, J., Conyard, E. and Murphy, K. D. (2020) ‘The potential contribution of medicines to falls in older persons and the acceptance of pharmacist intervention’, Health Services Research and Pharmacy Practice Conference, Cardiff, Wales, 16-17 April, in International Journal of Pharmacy Practice, 28 (S1), pp. 57-58. doi: 10.1111/ijpp.12607 en
dc.identifier.volume 28 en
dc.identifier.issued S1 en
dc.identifier.startpage 57 en
dc.identifier.endpage 58 en
dc.identifier.issn 0961-7671
dc.identifier.doi 10.1111/ijpp.12607 en
dc.description.abstract Introduction: Falls in older patients (≥65 years) is a growing burden on healthcare resources globally. Falls in older persons are responsible for 10–15% of presentations to acute hospitals and are the cause of > 50% of injury‐related hospitalisations in older persons1. Medicines are a modifiable risk factor for falls and the risk varies by class of medicine. Common medicine classes classified as Falls Risk Increasing Drugs (FRIDs) include antihypertensive agents, benzodiazepines, antidepressants, and neuroleptics2. The consequences of a fall can persist after discharge; patients have reported a reduction in quality of life up to 9 months after a fall and the fear of further falls has been associated with decreased physical activity. Aim: The aim of this study was to examine FRID use in older persons presenting with falls at Our Lady of Lourdes Hospital Drogheda (OLOL) in the Republic of Ireland, and the acceptance of a clinical pharmacist (CP) intervention in reducing FRIDs in this cohort. Methods: The study was conducted over a 6‐week period between June 1st and July 13th 2018 at OLOL in the Republic of Ireland. Consent was sought from patients who were ≥ 65 years, presented to the hospital with an acute fall or with injuries sustained due to an acute fall. Data collection involved patient demographics, admission details, reconciled medication list, and relevant patient observations and laboratory results. The CP provided written or oral medicines’ recommendations to physicians, and patient file was examined between July 16th and 20th to review uptake of the CP recommendations. Analysis was in the form of the extent of implementation of CP recommendations and review of polypharmacy. Results: There were 53 patients who took part in the study. There were slightly more females (52.8%) and the mean age was 81 ± 6.7 years. Most patients had had a previous fall (66.0%), with the majority having > 5 previous falls (52.8%). Fractures were reported by 39.6% with hip fractures being the most common type of fracture (11/53, 20.8%). The median number of medicines was 7 (IQR: 5–10.25). The median number of FRIDs was 2 (IQR: 1–3), with antihypertensives accounting for 73.0% (92/126) of FRIDs. The CP made 36 recommendations regarding 26 patients. Less than half (41.7%) of the CP recommendations were implemented. The most common drug classes with recommendations implemented were antihypertensives (19) and benzodiazepines (7). These were also the classes with the highest acceptance rate, with 57.9% of recommendations regarding antihypertensives (11/19) being accepted and 71.4% of recommendations for benzodiazepines being accepted (5/7). Conclusions: CPs have a role to play in highlighting the prescribing of FRIDs and in the reduction of the number of FRIDs taken by older persons with a history of falls. Reducing the number of falls will help older patients maintain their quality of life and reduce the number of acute hospital admissions in a stretched healthcare system. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Wiley en
dc.rights ©The Authors. IJPP © 2020 Royal Pharmaceutical Society en
dc.subject Older patients en
dc.subject Falls Risk Increasing Drugs (FRIDs) en
dc.subject Fallss en
dc.subject Intervention en
dc.subject Clinical pharmacist en
dc.subject Quality of life en
dc.title The potential contribution of medicines to falls in older persons and the acceptance of pharmacist intervention en
dc.type Conference item en
dc.internal.authorcontactother Kevin Murphy, School Of Pharmacy, University College Cork, Cork, Ireland. +353-21-490-3000 Email: en
dc.internal.availability Full text available en 2020-04-17T07:44:29Z
dc.description.version Accepted Version en
dc.internal.rssid 510842938
dc.description.status Peer reviewed en
dc.identifier.journaltitle International Journal of Pharmacy Practice en
dc.internal.copyrightchecked Yes
dc.internal.licenseacceptance Yes en
dc.internal.conferencelocation Cardiff, Wales en
dc.internal.IRISemailaddress en
dc.identifier.eissn 2042-7174

Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement